Anvisa greenlights CoronaVac for kids aged 3 to 5

Regulators have authorized the use of the Sinovac-developed Covid vaccine on children aged 3 to 5, but officials have already used the lion's share of available stocks

coronavac vaccine sinovac
Photo: Breno Esaki/Ag. Saúde DF

Brazil’s federal health regulator Anvisa on Wednesday authorized the emergency use of the Sinovac coronavirus vaccine on 3-to-5-year-olds. Sold under the brand name CoronaVac, the immunizer was the first to be rolled out in Brazil.

Butantan, a São Paulo-based biological institute which produces CoronaVac in Brazil, first sought authorization for the vaccine for children and teenagers back in July 2021. Anvisa rejected the request at the time, claiming that the data provided by the institute was insufficient to prove its security and efficacy.

In December 2021, Anvisa approved Pfizer’s Covid vaccine for children aged 5 to...

Access all of The Brazilian Report

Less expensive than a coffee!

Enjoy your 30-day limited-time offer for US$ 0.25 a week